Jose De La Cerda

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Urology San Antonio(Current)

Carolina Urologic Research Center

Jose De La Cerda is an author at Urology San Antonio specializing in castration-resistant prostate cancer therapy, prostate cancer hormone therapy, and pharmacology.

ORCID

Publications per year

2023–2024

Publications

ARV-766, a proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader, in metastatic castration-resistant prostate cancer (mCRPC): Initial results of a phase 1/2 study.

Daniel P. Petrylak, Meredith McKean, Joshua M. Lang et al. · Journal of Clinical Oncology · 2024 · 38 citations

Medicine, Oncology, Pharmacology +17

A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer

Jose De La Cerda, Curtis Dunshee, Lawrence Gervasi et al. · Targeted Oncology · 2023 · 15 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

1–2 of 2